Entrada Therapeutics (TRDA) vs Vogenx (VOGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Vogenx is the larger company by market cap ($176.3 million vs $170.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | TRDA | VOGX |
|---|---|---|
| Share price | $4.35 | $11.87 |
| Market cap | $170.30M | $176.33M |
| 1-day change | -6.25% | -7.30% |
| YTD return | -57.68% | — |
| 1-year return | -56.97% | — |
| 5-year return | -84.95% | — |
| EPS (TTM) | $-3.84 | $-0.89 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $25.42M | — |
| Revenue growth (YoY) | -87.94% | — |
| Net income (latest FY) | $-143.75M | — |
| Operating margin | -621.13% | — |
| Net margin | -565.48% | — |
| 52-week high | $16.45 | $38.41 |
| 52-week low | $4.11 | $11.51 |
| Distance from 52-week high | -73.56% | -69.10% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +308.05% | +363.35% |
| Average volume | 401.15K | 128.78K |
| Shares outstanding | 39.15M | 14.86M |
| Employees | 152 | 4 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Entrada Therapeutics
TRDA stock →Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 152 employees
About Vogenx
VOGX stock →Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis.
Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees
TRDA vs VOGX FAQ
Which is bigger, Entrada Therapeutics or Vogenx?
Vogenx (VOGX) is larger, with a market capitalization of $176.33M compared with $170.30M for Entrada Therapeutics (TRDA).
Are Entrada Therapeutics and Vogenx in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.